Institution statistics

MEDIZINISCHE HOCHSCHULE HANNOVER - Germany

Ranking results:

2012
Criterium:	Position:
Overall Score:	200-300
Total Project Funding:	> 1000
Total Project Funding:	> 1000
Total Project Funding:	> 1000
Total Project Funding per Partner:	> 1000
Total Project Funding per Partner:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Total Number of Projects:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
Partner Constancy:	> 1000
Partner Constancy:	> 1000
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Project Leadership Index:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	> 1000
Diversity Index:	> 1000
Diversity Index:	> 1000
2011
Criterium:	Position:
Overall Score:	400-500
Total Project Funding:	200-300
Total Project Funding per Partner:	200-300
Total Number of Projects:	100-200
Networking Rank (Reputation):	100-200
Partner Constancy:	300-400
Project Leadership Index:	200-300
Diversity Index:	> 1000
2010
Criterium:	Position:
Overall Score:	300-400
Total Project Funding:	600-700
Total Project Funding per Partner:	600-700
Total Number of Projects:	300-400
Networking Rank (Reputation):	700-800
Partner Constancy:	500-600
Project Leadership Index:	51
Diversity Index:	> 1000
2009
Criterium:	Position:
Overall Score:	500-600
Total Project Funding:	200-300
Total Project Funding per Partner:	100-200
Total Number of Projects:	200-300
Networking Rank (Reputation):	300-400
Partner Constancy:	300-400
Project Leadership Index:	600-700
Diversity Index:	500-600
2008
Criterium:	Position:
Overall Score:	900-1000
Total Project Funding:	700-800
Total Project Funding per Partner:	600-700
Total Number of Projects:	300-400
Networking Rank (Reputation):	400-500
Partner Constancy:	200-300
Project Leadership Index:	700-800
Diversity Index:	700-800
2007
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding:	> 1000
Total Project Funding per Partner:	800-900
Total Number of Projects:	400-500
Networking Rank (Reputation):	> 1000
Partner Constancy:	400-500
Project Leadership Index:	500-600
Diversity Index:	> 1000

European project participation (2000-01-01 - 2013-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Total funding / No of participants

Projects:

Leadership:

Total number of projects: 83
As coordinator: 9
As participant: 67
Sole participant: 7
Coordinator / Participant Ratio: 0.13^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2001	123.052	0	61.526	1
2004	0	18.669.613	1.029.460		5
2005	0	32.020.320	1.658.121		6
2006	24.849.809	69.684.000	3.782.394	3	8
2007	40.000	2.849.992	325.064	1	2
2008	0	17.056.029	1.305.442		7
2009	174.087	46.034.904	3.596.777	1	9
2010	3.670.071	19.611.180	1.877.519	4	5
2011	6.097.000	58.574.595	4.615.779	3	13
2012	5.200.000	36.760.951	5.013.961	1	9
2013	5.831.411	20.453.997	4.706.121	2	3

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	22
KATHOLIEKE UNIVERSITEIT LEUVEN	16
UNIVERSITY COLLEGE LONDON	16
LUNDS UNIVERSITET	13
CHARITE UNIVERSITAETSMEDIZIN BERLIN	10
KAROLINSKA INSTITUTE	10
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	7
LEIDEN UNIVERSITY MEDICAL CENTER	7
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	7
THE UNIVERSITY OF MANCHESTER	7
UNIVERSITA DEGLI STUDI DI PADOVA	7
UNIVERSITAET ULM	7
UNIVERSITAET ZUERICH	7
INSERM TRANSFERT	6
MEDIZINISCHE UNIVERSITAET WIEN	6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE	6
UNIVERSITAETSKLINIKUM FREIBURG	6
UNIVERSITE LIBRE DE BRUXELLES	6
UNIVERZITA KARLOVA V PRAZE	6
VRIJE UNIVERSITEIT BRUSSEL	6
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	5
COMMISSARIAT A L'ENERGIE ATOMIQUE	5
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	5
KING'S COLLEGE LONDON	5
MOSAIQUES DIAGNOSTICS	5
STICHTING KATHOLIEKE UNIVERSITEIT	5
UNIVERSITE DE GENEVE	5
UNIVERSITY OF GLASGOW	5
UNIVERSITY OF HELSINKI	5
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG	5
DEUTSCHES KREBSFORSCHUNGSZENTRUM	4
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	4
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR	4
GATC BIOTECH	4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	4
INSTITUT PASTEUR	4
REGION HOVEDSTADEN	4
THE HEBREW UNIVERSITY OF JERUSALEM	4
UNIVERSITA VITA SALUTE SAN RAFFAELE	4
UNIVERSITY COLLEGE DUBLIN	4
UNIVERSITY OF BRISTOL	4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	3
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN	3
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA	3
GENETHON	3
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT	3
LUND UNIVERSITY	3
MEDIZINISCHE UNIVERSITAET GRAZ	3
MILTENYI BIOTEC	3
MOLECULAR MEDICINE	3
OSLO UNIVERSITETSSYKEHUS HF	3
OSPEDALE PEDIATRICO BAMBINO GESU	3
PHILIPPS UNIVERSITAET MARBURG	3
TERVEYDEN JA HYVINVOINNIN LAITOS	3
UNIVERSITA CATTOLICA DEL SACRO CUORE	3
UNIVERSITA DEGLI STUDI DI PISA	3
UNIVERSITA DEGLI STUDI DI SIENA	3
UNIVERSITAET BASEL	3
UNIVERSITAET ROSTOCK	3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	3
UNIVERSITE CATHOLIQUE DE LOUVAIN	3
UNIVERSITE DE LAUSANNE	3
UNIVERSITE PARIS DESCARTES	3
UNIVERSITEIT MAASTRICHT	3
UNIVERSITY OF BIRMINGHAM	3
UNIVERSITY OF NEWCASTLE UPON TYNE	3
UNIVERSITY OF OSLO	3
UNIVERSITY OF SOUTHAMPTON	3
UNIVERSITY OF TROMSOE	3
UPPSALA UNIVERSITET	3
UPPSALA UNIVERSITY	3
WEIZMANN INSTITUTE OF SCIENCE	3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM	2
ACADEMISCH ZIEKENHUIS GRONINGEN	2
ACS BIOMARKER BV	2
AZIENDA OSPEDALIERA DI PADOVA	2
BAYERISCHE JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG	2
BAYERISCHE JULIUSMAXIMILIANSUNIVERSITaeT WueRZBURG	2
BIOCRATES LIFE SCIENCES	2
CENTRE HOSPITALIER UNIVERSITAIRE DE LIMOGES	2
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS	2
CHARLES UNIVERSITY PRAGUE 2 SCHOOL OF MEDICINE	2
CONSIGLIO NAZIONALE DELLE RICERCHE	2
CORLINE SYSTEMS AB	2
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA RECHERCHE ET DEVELOPPEMENT	2
DEMOCRITUS UNIVERSITY OF THRACE	2
EBERHARD KARLS UNIVERSITAET TUEBINGEN	2
EBERHARDKARLSUNIVERSITaeT TueBINGEN	2
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM	2
EUROPEAN MOLECULAR BIOLOGY LABORATORY	2
FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA	2
FONDAZIONE IRCCS OSPEDALE MAGGIORE POLICLINICO MANGIAGALLI E REGINA ELENA	2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	2
FUNDACAO CALOUSTE GULBENKIAN	2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA	2
GENETIC INTEREST GROUP	2

Constancy:

Total number of partners:1076

Partner loyalty:
Frequent Partner: (> 2 projects): 386
Rare Partner: 690

Frequent / Rare Partner Ratio: 0.56

Diversity:

Subjects:

Subject:	No:
HEALTH	38
MEDICINE	38
LIFE SCIENCES	34
BIOTECHNOLOGY	20
MEDICAL BIOTECHNOLOGY	11
SOCIAL ASPECTS	8
TRAINING	6
EDUCATION	6
HEALTHCARE DELIVERY/SERVICES	4
REGIONAL DEVELOPMENT	4
INFORMATION	3
NANOTECHNOLOGY AND NANOSCIENCES	3
ECONOMIC ASPECTS	3
MEDIA	3
MATERIALS TECHNOLOGY	2
INDUSTRIAL MANUFACTURE	2
AGRICULTURAL BIOTECHNOLOGY	1
ENVIRONMENTAL PROTECTION	1
OTHER ENERGY TOPICS	1
TRANSPORT	1
ENERGY STORAGE	1
NETWORK TECHNOLOGIES	1
ENERGY SAVING	1
ENERGY TRANSPORT	1

Diversity index:0.48

Categories:

Category:	No:
BIOLOGICAL SCIENCES	58
RTD HORIZONTAL TOPICS	13
INDUSTRY AND TECHNOLOGY	6
ENERGY	2
SOCIAL AND ECONOMIC CONCERNS	1
AGRICULTURE AND MARINE RESOURC	1

Project overview:

Start date	Project	acronym	role	funding	partners
2013-04-01	Lymph node homing of immune cells via afferent lymphatics mechanisms and immune response	LYMPHATICS-HOMING	coordinator	2.491.200	1
2013-03-01	Biomarkers of renal graft injuries in kidney allograft recipients	BIOMARGIN	participant	6.000.000	13
2013-02-01	Model Driven Computation of Treatments for Infertility Related Endocrinological Diseases	PAEON	participant	2.453.997	5
2013-02-01	Heart OMics in AGEing	HOMAGE	participant	12.000.000	17
2013-01-01	Towards Tissue Engineering Solutions for Cardiovascular Surgery	TECAS	coordinator	3.340.211	6
2012-12-01	Orphans Unite: chILD better together European Management Platform for Childhood Interstitial Lung Diseases	CHILD-EU	participant	3.000.000	10
2012-10-01	Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies	CELLEUROPE	participant	3.226.319	10
2012-10-01	Natural Killer Cell-Based Anti-Cancer Immunotherapies: Research training in molecular medicine and biotechnology business	NATURIMMUN	participant	3.526.286	11
2012-10-01	Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders.	TS-EUROTRAIN	participant	3.076.397	10
2012-09-01	Improving the organisation of maternal health service delivery, and optimising childbirth, by increasing vaginal birth after caesarean section (VBAC) through enhanced women-centred care	OPTIBIRTH	participant	2.999.263	11
2012-09-01	Neurotrophic Cochlear Implant for Severe Hearing Loss	NEUEAR	participant	5.843.872	5
2012-07-01	A novel micronutrient-based strategy to prevent hearing impairments: test and road to market for age-related hearing loss and preservation of residual hearing	PROHEARING	participant	5.096.600	5
2012-05-01	New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier	TRANS-INT	participant	8.000.000	17
2012-01-01	Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China	IMMUNOCAN	participant	1.992.214	5
2012-01-01	European clinical study for the application of regenerative heart valves	ESPOIR	coordinator	5.200.000	12
2011-12-01	European Multicentre Tics in Children Studies	EMTICS	participant	6.000.000	27
2011-12-01	Markers for Sub-Clinical Cardiovascular Risk Assessemnt	EU-MASCARA	participant	5.990.880	15
2011-11-01	The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction	BAMI	participant	5.993.083	21
2011-11-01	Overcome failure to Publish nEgative fiNdings	OPEN	participant	499.991	11
2011-10-01	Biomarker for Cardiovascular Risk Assessment in Europe	BIOMARCARE	participant	6.000.000	29
2011-10-01	Multi-scale Biological Modalities for Physiological Human Articulation	MULTISCALEHUMAN	participant	3.561.930	7
2011-10-01	Biohybrid templates for peripheral nerve regeneration	BIOHYBRID	coordinator	5.922.000	10
2011-10-01	Dobutamine for NEOnatal CIRCulatory failure defined by novel biomarkers	NEO-CIRC	participant	5.999.167	18
2011-10-01	International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research	INTREALL	participant	5.998.055	23
2011-10-01	Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes	BETABAT	participant	5.999.000	10
2011-08-01	Endocannabinoid signaling in heart failure: functional relevance of microRNAs	ENSIG-MIRNA	coordinator	75.000	1
2011-07-01	Molecular imaging of the myocardium to facilitate cardiac stem cell therapy	STEM CELL IMAGING	coordinator	100.000	1
2011-04-01	Corline Heparin Technology - Enabling Regenerative Medicine	CORLINE	participant	1.135.500	11
2011-01-01	HEPATIC MICROFLUIDIC BIOREACTOR	HEMIBIO	participant	4.700.000	12
2011-01-01	Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services	EUROGENTEST2	participant	1.996.989	20
2011-01-01	HEPATIC MICROFLUIDIC BIOREACTOR	HEMIBIO	participant	4.700.000	12
2010-12-01	International Research on Quality in Healthcare	INTERQUALITY	participant	2.950.129	9
2010-11-01	Preparation for Moldova s integration into the European Research Area and into the Community R&D Framework Programs on the basis of scientific excellence	MOLD-ERA	participant	498.888	6
2010-11-01	OPTImization of the automated Fitting to Outcomes eXpert with language-independent hearing-in-noise test battery and electro-acoustical test box for cochlear implant users	OPTI-FOX	participant	1.274.928	10
2010-11-01	Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency	CELL-PID	participant	11.887.735	19
2010-11-01	Host and viral factors in acute hepatitis C	HEPACUTE	participant	2.999.500	17
2010-09-01	The impact of Regulation (EC) No 1394/2007 on the development of Advanced Therapy Medicinal Products (ATMPs): an academic perspective	ACADEMIC GMP	coordinator	498.747	8
2010-06-01	Functional analysis of the neonatal B cell compartment	NEONATAL B CELLS	coordinator	100.000	1
2010-02-01	The role of adenosine in placental development and function	ADENOSINE	coordinator	75.000	1
2010-01-01	Neuroscience on barriers in development	NEUROBID	coordinator	2.996.324	10
2009-12-01	Keratinocytes and Matrix metalloproteinases: Driving force of skin wound contraction?	WOUND CONTRACTION	participant	1.299.840	2
2009-11-01	Novel immunotherapies for type 1 diabetes	NAIMIT	participant	10.920.800	15
2009-10-01	Studies Investigating Co-morbidities Aggravating Heart Failure	SICA-HF	participant	2.999.358	13
2009-10-01	Molecular motors-based nanodevices	MONAD	participant	2.646.773	9
2009-05-01	Understanding of ORMDL3 biology will provide novel insight into the pathogenesis of asthma	ASTHMA AND ORMDL3	coordinator	174.087	1
2009-04-01	Child advanced safety project for european roads	CASPER	participant	3.854.265	15
2009-04-01	European networks of centres of expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation)	ENCE-CF-LAM-LTX	participant	857.310	8
2009-02-01	Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics	MITOTARGET	participant	5.969.416	18
2009-01-01	Persisting transgenesis	PERSIST	participant	11.181.411	26
2009-01-01	Bioactive highly porous and injectable scaffolds controlling stem cell recruitment, proliferation and differentiation and enabling angiogenesis for cardiovascular engineered tissues	BIOSCENT	participant	6.305.731	16

overview shows latest 50 from 83 projects (2000-01-01 - 2013-12-31)

Alias institution names:

MEDIZINISCHE HOCHSCHULE HANNOVER